CD274 and non-small cell lung carcinoma: Recently, the nab‐paclitaxel plus carboplatin combination was used as chemotherapy backbone for several large phase 3 trials investigating PD‐1/PD‐L1 blockade in combination with chemotherapy for therapy of metastatic NSCLC with squamous or non‐squamous histology.10, 11, 13, 25, 26